<DOC>
	<DOC>NCT00018564</DOC>
	<brief_summary>This clinical research program is designed to evaluate medications as new treatments for essential tremor. Essential tremor is a common condition with few available therapies.</brief_summary>
	<brief_title>Novel Therapies for Essential Tremor</brief_title>
	<detailed_description>Each medication will be evaluated for effectiveness against tremor in a randomized, placebo-controlled, cross-over, double blind clinical research trial. Tremor will be assessed with accepted rating scales and accelerometry</detailed_description>
	<mesh_term>Tremor</mesh_term>
	<mesh_term>Essential Tremor</mesh_term>
	<criteria>1. Diagnosis of essential tremor. 2. Tremor rating scale score 3 or one or both upper extremities 3. Unsatisfactory response to primidone or to propanolol 4. Not taking tremorinducing drug 5. Able to comply with visits</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2004</verification_date>
</DOC>